NeuralCure AI Launches First Diagnostic & Digital Twin OS to Power Patient-Led Healthcare Revolution

NeuralCure AI  announced the official launch of its groundbreaking Diagnostic & Digital Twin Operating System, the first infrastructure platform...

June 20, 2025 | Friday | News
Symbiotic.blue Launches in the UK to Redesign Drug Discovery with Brain-Inspired AI

Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial intelligence-driven drug discovery (AIDD) pla...

June 20, 2025 | Friday | News
Synfini and O2nix Bio Partner to Accelerate Anti-Metastatic Cancer Drug Discovery Targeting FTSJ1

Combination of World Leading Epitranscriptomics and AI-Driven Automation Aims to Accelerate Development of Cancer Therapies That Halt Metastasis  &...

June 19, 2025 | Thursday | News
BioAro Launches PanOmiQ™ Research, Setting a New Standard for AI-Driven Multi-Omics and Drug Discovery

AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery.PanOmiQ™ Research sets a new global benchmark for prec...

June 17, 2025 | Tuesday | News
EDETEK Partners with Capgemini to Accelerate AI-Driven Digital Transformation in Clinical Development

  EDETEK Inc., a global provider of leading AI-driven clinical development platforms and services, has engaged Capgemini to support its ongoing advan...

June 11, 2025 | Wednesday | News
IonQ, AstraZeneca, AWS, and NVIDIA Achieve 20x Speedup in Quantum-Accelerated Drug Development Workflow

Largest demonstration of its kind combines leading hardware, platforms, and techniques to achieve 20 times speedup over previous demonstrations Ecosys...

June 10, 2025 | Tuesday | News
MIT, Recursion, and NVIDIA Launch Boltz-2: Open-Source AI Model Sets New Standard for Binding Affinity Prediction

Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free...

June 09, 2025 | Monday | News
ByteBrain Launches MEDRAIL to Transform Clinical Trials with AI-Powered Compliance and Safety Automation

ByteBrain LLC, an emerging AI research and consulting firm, has announced the launch of MEDRAIL, an intelligent platform designed to help pharmaceutical co...

June 06, 2025 | Friday | News
The Challenge of Modern Drug Discovery

Enter Generative AI: A Paradigm Shift Today, generative AI is changing this equation. Unlike traditional AI that analyzes existing data, generative AI can...

June 03, 2025 | Tuesday | Expert Opinion
Synfini and Multispan Join Forces to Accelerate GPCR Drug Discovery Using AI and Automation

Synfini, Inc., the leader in AI-driven agile chemistry for better molecule discovery, announced today that it has entered a collaboration with biotechnol...

May 22, 2025 | Thursday | News
Juvena Therapeutics Begins Clinical Trial of JUV-161, a First-in-Class Muscle Regenerating Biologic for Myotonic Dystrophy

JUV-161 is a first-in-class muscle regenerating biologic that will address myopathies starting with Myotonic Dystrophy Type 1 JUV-161 was discovered ...

May 20, 2025 | Tuesday | News
Azenta’s GENEWIZ and Form Bio Partner to Accelerate AAV Gene Therapy Development with Integrated Sequencing and AI Analysis

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. Azenta, Inc.a...

May 14, 2025 | Wednesday | News
OmniAb Showcases xPloration Platform at PEGS Boston to Transform Antibody Discovery with AI-Powered Single B-Cell Screening

xPloration Maximizes Impact for OmniAb’s Partners through Efficient and Precise Mining of Immunized Antibody Repertoires OmniAb, Inc. &n...

May 14, 2025 | Wednesday | News
MaxisIT Evolves into Maxis AI, Launches Agentic AI Platform to Transform Clinical Trials

MaxisIT, a long-recognized provider of clinical data analytics platform for clinical trials, today announced its transformation into Maxis AI. This strat...

May 13, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close